Evoke Pharma, Inc. (EVOK) Dividend History

Evoke Pharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing treatments for rare and underserved diseases. Its primary product is Gimoti, an oral solution for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company aims to address unmet medical needs through innovative drug formulations and targeted therapies.

420 Stevens Avenue, Solana Beach, CA, 92075
Phone: 858-345-1494
Website: https://www.evokepharma.com

Dividend History

Evoke Pharma, Inc. currently does not pay dividends

Company News

By popular demand: SiGMA Europe launches fourth shed

SiGMA Europe is expanding its floor plan with an additional 15,000 square metres of exhibition space, accommodating 1,000 sponsors and exhibitors. The event is expected to welcome a record-breaking 27,000 delegates, solidifying Malta's position as a hub for the global gaming community.

GlobeNewswire Inc.
Questex’s Fierce Pharma Announces the 2024 Fierce Pharma Marketing Awards Winners

The article announces the winners of the 2024 Fierce Pharma Marketing Awards and the Health Union Social Health Awards. It also mentions the upcoming Digital Pharma East virtual conference.

GlobeNewswire Inc.

Featured Companies: PFE TARS
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results

Evoke Pharma reported strong Q2 2024 results, with GIMOTI net product sales growing 47% quarter-over-quarter and 126% year-over-year. The company achieved record-high prescription fills and presented data on GIMOTI's benefits at medical meetings.

GlobeNewswire Inc.
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI

Expanded State Medicaid Access for GIMOTI

GlobeNewswire Inc.
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference

Evoke commercial booth located at site #737 Evoke commercial booth located at site #737

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 20:04:34 UTC